vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Urban Edge Properties (UE). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $132.6M, roughly 1.1× Urban Edge Properties). Urban Edge Properties runs the higher net margin — 17.1% vs 7.8%, a 9.3% gap on every dollar of revenue. On growth, Urban Edge Properties posted the faster year-over-year revenue change (12.2% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 11.6%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Urban Edge Properties is a publicly traded real estate investment trust (REIT) that owns, operates, and develops high-quality retail and mixed-use properties, primarily located in densely populated urban and suburban markets across the United States. Its portfolio covers grocery-anchored shopping centers, lifestyle outlets, and community-focused commercial assets.
NUTX vs UE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $132.6M |
| Net Profit | $11.8M | $22.6M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | — |
| Net Margin | 7.8% | 17.1% |
| Revenue YoY | -41.1% | 12.2% |
| Net Profit YoY | -80.8% | -6.7% |
| EPS (diluted) | $2.34 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $132.6M | ||
| Q4 25 | $151.7M | $119.6M | ||
| Q3 25 | $267.8M | $120.1M | ||
| Q2 25 | $244.0M | $114.1M | ||
| Q1 25 | $211.8M | $118.2M | ||
| Q4 24 | $257.6M | $116.4M | ||
| Q3 24 | $78.8M | $112.4M | ||
| Q2 24 | $76.1M | $106.5M |
| Q1 26 | — | $22.6M | ||
| Q4 25 | $11.8M | $12.4M | ||
| Q3 25 | $55.4M | $14.9M | ||
| Q2 25 | $-17.7M | $58.0M | ||
| Q1 25 | $21.2M | $8.2M | ||
| Q4 24 | $61.6M | $30.1M | ||
| Q3 24 | $-8.8M | $9.1M | ||
| Q2 24 | $-364.0K | $30.8M |
| Q1 26 | — | — | ||
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 20.4% | 11.3% | ||
| Q3 25 | 48.7% | 13.4% | ||
| Q2 25 | 13.8% | 53.9% | ||
| Q1 25 | 38.1% | 7.6% | ||
| Q4 24 | 44.4% | 27.6% | ||
| Q3 24 | 12.3% | 8.9% | ||
| Q2 24 | 7.0% | 30.6% |
| Q1 26 | — | 17.1% | ||
| Q4 25 | 7.8% | 10.4% | ||
| Q3 25 | 20.7% | 12.4% | ||
| Q2 25 | -7.3% | 50.8% | ||
| Q1 25 | 10.0% | 6.9% | ||
| Q4 24 | 23.9% | 25.9% | ||
| Q3 24 | -11.2% | 8.1% | ||
| Q2 24 | -0.5% | 28.9% |
| Q1 26 | — | $0.18 | ||
| Q4 25 | $2.34 | $0.09 | ||
| Q3 25 | $7.76 | $0.12 | ||
| Q2 25 | $-2.95 | $0.46 | ||
| Q1 25 | $3.33 | $0.07 | ||
| Q4 24 | $11.56 | $0.25 | ||
| Q3 24 | $-1.72 | $0.07 | ||
| Q2 24 | $-0.07 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $50.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $1.4B |
| Total Assets | $918.5M | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $50.0M | ||
| Q4 25 | $185.6M | $48.9M | ||
| Q3 25 | $166.0M | $77.8M | ||
| Q2 25 | $96.7M | $53.0M | ||
| Q1 25 | $84.7M | $48.0M | ||
| Q4 24 | $40.6M | $41.4M | ||
| Q3 24 | $46.9M | $67.9M | ||
| Q2 24 | $40.8M | $78.6M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $329.4M | $1.4B | ||
| Q3 25 | $317.2M | $1.4B | ||
| Q2 25 | $235.3M | $1.4B | ||
| Q1 25 | $176.9M | $1.4B | ||
| Q4 24 | $132.4M | $1.4B | ||
| Q3 24 | $60.4M | $1.3B | ||
| Q2 24 | $62.7M | $1.3B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $918.5M | $3.3B | ||
| Q3 25 | $964.5M | $3.3B | ||
| Q2 25 | $841.0M | $3.3B | ||
| Q1 25 | $761.9M | $3.3B | ||
| Q4 24 | $655.3M | $3.3B | ||
| Q3 24 | $438.5M | $3.2B | ||
| Q2 24 | $422.4M | $3.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $39.1M |
| Free Cash FlowOCF − Capex | $69.0M | — |
| FCF MarginFCF / Revenue | 45.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | 1.5% |
| Cash ConversionOCF / Net Profit | 5.95× | 1.73× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $39.1M | ||
| Q4 25 | $70.4M | $182.7M | ||
| Q3 25 | $99.5M | $55.7M | ||
| Q2 25 | $27.3M | $43.5M | ||
| Q1 25 | $51.0M | $32.6M | ||
| Q4 24 | $54.0K | $153.2M | ||
| Q3 24 | $6.8M | $36.6M | ||
| Q2 24 | $13.3M | $41.2M |
| Q1 26 | — | — | ||
| Q4 25 | $69.0M | $81.8M | ||
| Q3 25 | $99.2M | $26.1M | ||
| Q2 25 | $26.5M | $19.6M | ||
| Q1 25 | $50.9M | $11.9M | ||
| Q4 24 | $-341.0K | $42.5M | ||
| Q3 24 | $6.2M | $12.2M | ||
| Q2 24 | $12.7M | $19.9M |
| Q1 26 | — | — | ||
| Q4 25 | 45.5% | 68.4% | ||
| Q3 25 | 37.0% | 21.7% | ||
| Q2 25 | 10.9% | 17.2% | ||
| Q1 25 | 24.0% | 10.0% | ||
| Q4 24 | -0.1% | 36.6% | ||
| Q3 24 | 7.8% | 10.8% | ||
| Q2 24 | 16.7% | 18.6% |
| Q1 26 | — | 1.5% | ||
| Q4 25 | 0.9% | 84.4% | ||
| Q3 25 | 0.1% | 24.6% | ||
| Q2 25 | 0.3% | 20.9% | ||
| Q1 25 | 0.0% | 17.5% | ||
| Q4 24 | 0.2% | 95.1% | ||
| Q3 24 | 0.8% | 21.7% | ||
| Q2 24 | 0.7% | 20.1% |
| Q1 26 | — | 1.73× | ||
| Q4 25 | 5.95× | 14.71× | ||
| Q3 25 | 1.80× | 3.73× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | 2.40× | 3.97× | ||
| Q4 24 | 0.00× | 5.09× | ||
| Q3 24 | — | 4.03× | ||
| Q2 24 | — | 1.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
UE
| Rental revenue | $124.2M | 94% |
| Other | $8.4M | 6% |
